In order to do this, we have used a gene editing approach to introduce these variants into the endogenous mouse Cfap410 gene instead of overexpressing these, so as to have a physiologically relevant model which recapitulates the effects seen in human ALS. Here, CFAP410 is linked to amyotrophic lateral sclerosis.